XP Chemistries (XPC) Q2 2024 earnings summary

Executive summary

• XP Chemistries focuses on sustainable, high-purity capsaicin production for animal feed and other applications, advancing its EFSA approval process for feed use in Europe.

• The company is preparing for a 2025 product launch, strengthening customer relationships and expanding production and distribution capabilities.

Financial highlights

• Net sales for Jan–Jun 2024 were 200 TSEK, down from 470 TSEK year-over-year; Q2 sales were 149 TSEK, down from 198 TSEK.

• Operating loss for Jan–Jun 2024 was -4,569 TSEK, improved from -5,340 TSEK; Q2 operating loss was -2,243 TSEK, improved from -2,801 TSEK.

• Net loss before tax for Jan–Jun 2024 was -4,546 TSEK, compared to -5,316 TSEK; Q2 net loss before tax was -2,253 TSEK, compared to -2,772 TSEK.

• Earnings per share for Jan–Jun 2024 was -0.04 SEK, improved from -0.15 SEK; Q2 EPS was -0.02 SEK, improved from -0.08 SEK.

• Cash and cash equivalents at June 30, 2024, were 3,152 TSEK, down from 9,595 TSEK a year earlier.

Outlook and guidance

• EFSA's scientific evaluation of the capsaicin feed additive is expected to conclude by year-end 2024.

• The company is preparing for a commercial launch in 2025, focusing on market expansion and operational readiness.